{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:45:33Z","timestamp":1793259933960,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171014"],"award-info":[{"award-number":["82171014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exer.2026.111133","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:41:53Z","timestamp":1781883713000},"page":"111133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The neuro-immune-epithelial axis in dry eye: From pathogenic crosstalk to neuromodulatory therapies"],"prefix":"10.1016","volume":"270","author":[{"given":"Jiehao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-144X","authenticated-orcid":false,"given":"Zhijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111133_bib1","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1167\/iovs.03-1366","article-title":"Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers","volume":"45","author":"Acosta","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib2","doi-asserted-by":"crossref","DOI":"10.5935\/0004-2749.2024-0202","article-title":"Evaluation of the relationship between dry eye syndrome severity and corneal sensitivity","volume":"88","author":"Akgun","year":"2025","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.exer.2026.111133_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1362336","article-title":"Single-cell analysis of short-term dry eye-induced changes in cornea immune cell populations","volume":"11","author":"Alam","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2026.111133_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1167\/iovs.06-0127","article-title":"Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye","volume":"48","author":"Ben\u00edtez-Del-Castillo","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib5","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.3390\/jcm14155250","article-title":"Clinical characterization of the lacrimal functional unit in patients with chronic ocular pain associated with dry eye disease","volume":"14","author":"Blanco-V\u00e1zquez","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2026.111133_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","article-title":"Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib7","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1167\/iovs.04-1426","article-title":"Decreased corneal sensitivity in patients with dry eye","volume":"46","author":"Bourcier","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib8","series-title":"Canadian Agency for Drugs and Technologies in Health","article-title":"Cenegermin (Oxervate): CADTH reimbursement recommendation","year":"2022"},{"key":"10.1016\/j.exer.2026.111133_bib9","article-title":"Low-level light therapy and intense pulse light therapy in meibomian gland dysfunction: a systematic review and meta-analysis","author":"Chan","year":"2024","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.exer.2026.111133_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.mucimm.2024.06.002","article-title":"Activation of the SST-SSTR5 signaling pathway enhances corneal wound healing in diabetic mice","volume":"17","author":"Chen","year":"2024","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib11","article-title":"Meibomian gland features in a Norwegian cohort of patients with primary Sj\u00f6gren's syndrome","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2026.111133_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/opo.13186","article-title":"The impact of dry eye disease on corneal nerve parameters: a systematic review and meta-analysis","volume":"43","author":"Chiang","year":"2023","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.exer.2026.111133_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12886-025-04146-0","article-title":"Safety and efficacy of rebamipide compared to artificial tears for the treatment of dry eye: a systematic review and meta-analysis","volume":"25","author":"Chiu","year":"2025","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3109\/02713683.2015.1098707","article-title":"Expression of lipid peroxidation markers in the tear film and ocular surface of patients with non-sjogren syndrome: potential biomarkers for dry eye disease","volume":"41","author":"Choi","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2026.111133_bib15","unstructured":"ClinicalTrials.gov, n.d.a. Safety and Efficacy Study on Cenegermin (Oxervate) Vs Vehicle in Severe Sj\u00f6gren's Dry Eye Disease (PROTEGO-1). ClinicalTrials.gov identifier: NCT05133180. https:\/\/clinicaltrials.gov\/study\/NCT05133180 (accessed 29 May 2026)."},{"key":"10.1016\/j.exer.2026.111133_bib16","unstructured":"ClinicalTrials.gov, n.d.b. Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate) Vs Vehicle in Severe Sj\u00f6gren's Dry Eye Disease Treated with Cyclosporine A (PROTEGO-2). ClinicalTrials.gov identifier: NCT05136170. https:\/\/clinicaltrials.gov\/study\/NCT05136170 (accessed 29 May 2026)."},{"key":"10.1016\/j.exer.2026.111133_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9394(03)00897-3","article-title":"Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation","volume":"137","author":"De Paiva","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib18","first-page":"52973","article-title":"Medical devices; ophthalmic devices; classification of the intranasal electrostimulation device for dry eye symptoms","volume":"83","year":"2018","journal-title":"Fed. Regist."},{"key":"10.1016\/j.exer.2026.111133_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.exer.2026.111133_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.31083\/j.fbl2905175","article-title":"TRPV1 in dry eye disease","volume":"29","author":"Gou","year":"2024","journal-title":"Front. Biosci. Landmark Ed."},{"key":"10.1016\/j.exer.2026.111133_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.eye.6701760","article-title":"Morphology of corneal nerves and corneal sensation in dry eye: a preliminary study","volume":"19","author":"Ho\u015fal","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.exer.2026.111133_bib21","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s12325-022-02194-2","article-title":"Efficacy and safety of the long-acting diquafosol ophthalmic solution DE-089C in patients with dry eye: a randomized, double-masked, placebo-controlled phase 3 study","volume":"39","author":"Hori","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.exer.2026.111133_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajo.2025.11.036","article-title":"Efficacy and safety of SJP-0132 in patients with dry eye disease: a phase 2b randomized, double-masked, dose-finding study","volume":"283","author":"Hori","year":"2026","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2024.1449283","article-title":"Multidimensional immunotherapy for dry eye disease: current status and future directions","volume":"4","author":"Huang","year":"2024","journal-title":"Front. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.12.23","article-title":"Novel extranasal tear stimulation: pivotal study results","volume":"9","author":"Ji","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.exer.2026.111133_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110574","article-title":"Redefining tear film biology: immune regulation, multi-omics integration, and systemic disease interfaces","volume":"259","author":"Jiao","year":"2025","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111133_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","article-title":"TFOS DEWS III management and therapy report","volume":"279","author":"Jones","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12886-023-02857-w","article-title":"Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery","volume":"23","author":"Kang","year":"2023","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib30","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajo.2013.11.010","article-title":"A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye","volume":"157","author":"Kinoshita","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/tjo.TJO-D-25-00110","article-title":"Integrating secretagogues into clinical dry eye care: insights from Asian clinical experience","volume":"15","author":"Koh","year":"2025","journal-title":"Taiwan J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2025.11.005","article-title":"Corneal sensitivity in dry eye disease: a systematic review","volume":"39","author":"K\u00e4ser","year":"2026","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib34","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1167\/iovs.11-8708","article-title":"The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease","volume":"53","author":"Labb\u00e9","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib35","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1167\/iovs.13-12370","article-title":"Corneal nerve structure and function in patients with Non-Sj\u00f6gren dry eye","volume":"54","author":"Labb\u00e9","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib36","first-page":"327","article-title":"P2Y2 receptor agonists for the treatment of dry eye disease: a review","volume":"8","author":"Lau","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ceo.12898","article-title":"Increased corneal sub-basal nerve density in patients with Sj\u00f6gren syndrome treated with topical cyclosporine A","volume":"45","author":"Levy","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40123-022-00616-6","article-title":"Effectiveness of intranasal tear neurostimulation for treatment of dry eye disease: a meta-analysis","volume":"12","author":"Li","year":"2023","journal-title":"Ophthalmol. Ther"},{"key":"10.1016\/j.exer.2026.111133_bib39","article-title":"Ocular surface epithelial thickness evaluation in dry eye patients: clinical correlations","volume":"2016","author":"Liang","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1684290","article-title":"NF-\u03baB\/IL-6 axis drives impaired corneal wound healing in aqueous-deficient dry eye","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41385-022-00533-8","article-title":"TRPV1+ sensory nerves modulate corneal inflammation after epithelial abrasion via RAMP1 and SSTR5 signaling","volume":"15","author":"Liu","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib43","article-title":"Influence of dendritic cells on corneal nerve morphological analysis and clinical relevance in chronic dry eye disease after femtosecond laser-assisted laser in situ keratomileusis","volume":"12","author":"Liu","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2026.111133_bib41","article-title":"Resident innate immune cells in the cornea","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jtos.2022.07.003","article-title":"In vivo confocal microscopic study of corneal innervation in Sj\u00f6gren's syndrome with or without small fiber neuropathy","volume":"25","author":"Luzu","year":"2022","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajo.2026.02.031","article-title":"Defining discordance between signs and symptoms in dry eye disease: insights from the DRy Eye Assessment and management (DREAM) study","volume":"286","author":"Matar","year":"2026","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaophthalmol.2023.5751","article-title":"Interventions for dry eye: an overview of systematic reviews","volume":"142","author":"McCann","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2026.111133_bib47","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1167\/iovs.16-19309","article-title":"Reduced levels of tear lacritin are associated with corneal neuropathy in patients with the ocular component of Sj\u00f6gren's syndrome","volume":"57","author":"McNamara","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12034","article-title":"PACAP suppresses dry eye signs by stimulating tear secretion","volume":"7","author":"Nakamachi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2026.111133_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000492896","article-title":"Efficacy and safety of topical 3% diquafosol ophthalmic solution for the treatment of multifactorial dry eye disease: meta-analysis of randomized clinical trials","volume":"61","author":"Nam","year":"2019","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2026.111133_bib50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nm.2264","article-title":"Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea","volume":"16","author":"Parra","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2026.111133_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ophtha.2025.09.018","article-title":"Acoltremon ophthalmic solution 0.003% for signs and symptoms of dry eye disease: results of phase 3 pivotal COMET-2 and COMET-3 studies","volume":"133","author":"Pattar","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical recombinant human nerve growth factor (cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial","volume":"127","author":"Pflugfelder","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2021.12.007","article-title":"A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: the MYSTIC study","volume":"24","author":"Quiroz-Mercado","year":"2022","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ajo.2015.08.005","article-title":"Corneal sensitivity in tear dysfunction and ocular surface disease","volume":"160","author":"Rahman","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2025.06.005","article-title":"Ocular surface epithelial immune cells and corneal nerves in dry eye disease: a systematic review and meta-analysis of in vivo confocal microscopy data","volume":"38","author":"Sadhu","year":"2025","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib56","series-title":"Obtained Manufacturing and Marketing Approval in Japan for Avarept Ophthalmic Suspension 0.3%, a Novel Treatment of Dry Eye Disease Through Transient Receptor Potential Cation Channel Subfamily V Member 1 Inhibition","year":"2025"},{"key":"10.1016\/j.exer.2026.111133_bib57","series-title":"Launch of Avarept Ophthalmic Suspension 0.3% in Japan, a Novel Treatment of Dry Eye Disease Through TRPV1 Inhibition","year":"2026"},{"key":"10.1016\/j.exer.2026.111133_bib58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtos.2018.11.009","article-title":"Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: results from two pivotal clinical trials","volume":"17","author":"Sheppard","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib59","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1167\/iovs.08-1734","article-title":"Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness","volume":"49","author":"Situ","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jtos.2018.08.004","article-title":"Corneal hyperalgesia in patients with short tear film break-up time dry eye","volume":"17","author":"Tagawa","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2026.111133_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICO.0b013e3181acf68d","article-title":"Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy","volume":"29","author":"Toker","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2026.111133_bib62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.exer.2008.03.002","article-title":"Alterations in corneal sensitivity and nerve morphology in patients with primary Sj\u00f6gren syndrome","volume":"86","author":"Tuisku","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111133_bib63","series-title":"RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05% Prescribing Information","year":"2012"},{"key":"10.1016\/j.exer.2026.111133_bib71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/02713683.2010.484557","article-title":"Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases","volume":"35","author":"Versura","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2026.111133_bib72","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s40123-024-00998-9","article-title":"Detection of subclinical neurotrophic keratopathy by noncontact esthesiometry","volume":"13","author":"Villalba","year":"2024","journal-title":"Ophthalmol. Ther"},{"key":"10.1016\/j.exer.2026.111133_bib73","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1167\/iovs.06-1129","article-title":"The cornea in Sj\u00f6gren's syndrome: an in vivo confocal study","volume":"48","author":"Villani","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib74","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41433-024-03060-x","article-title":"Corneal neuropathic pain: a review to inform clinical practice","volume":"38","author":"Watson","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.exer.2026.111133_bib77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12886-024-03564-w","article-title":"Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trial","volume":"24","author":"Wirta","year":"2024","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/ICO.0000000000002941","article-title":"ONSET-1 phase 2b randomized trial to evaluate the safety and efficacy of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease","volume":"41","author":"Wirta","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2026.111133_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease: the ONSET-2 phase 3 randomized trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111133_bib78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"Tfos DEWS III: diagnostic methodology","volume":"279","author":"Wolffsohn","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111133_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s42003-018-0270-9","article-title":"Acute tobacco smoke exposure exacerbates the inflammatory response to corneal wounds in mice via the sympathetic nervous system","volume":"2","author":"Xiao","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.exer.2026.111133_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00003226-199605000-00002","article-title":"Decrease in corneal sensitivity and change in tear function in dry eye","volume":"15","author":"Xu","year":"1996","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2026.111133_bib81","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41385-018-0031-6","article-title":"The mouse autonomic nervous system modulates inflammation and epithelial renewal after corneal abrasion through the activation of distinct local macrophages","volume":"11","author":"Xue","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mucimm.2024.02.009","article-title":"Stress systems exacerbate the inflammatory response after corneal abrasion in sleep-deprived mice via the IL-17 signaling pathway","volume":"17","author":"Xue","year":"2024","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.exer.2026.111133_bib84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/ICL.0000000000000904","article-title":"Evaluation of ocular surface characteristics in dry eye disease with and without soft contact lens wear: a comparative study","volume":"48","author":"Yang","year":"2022","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.exer.2026.111133_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2026.110970","article-title":"Molecular mechanisms and pathophysiology of meibomian gland dysfunction","volume":"267","author":"Yang","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111133_bib85","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.09-3425","article-title":"Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome","volume":"51","author":"Yoon","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111133_bib86","article-title":"Tear neuropeptides are associated with clinical symptoms and signs of dry eye patients","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.exer.2026.111133_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.66.5.13","article-title":"Targeting \u03b17 nicotinic acetylcholine receptor for modulating the neuroinflammation of dry eye disease via macrophages","volume":"66","author":"Zhou","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:29:24Z","timestamp":1785893364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"alternative-id":["S0014483526002897"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111133","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuro-immune-epithelial axis in dry eye: From pathogenic crosstalk to neuromodulatory therapies","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111133"}}